Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 22Neoplasms 9Pulmonary Embolism 6Venous Thrombosis 5Thrombosis 4Multiple Myeloma 3Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Upper Extremity Deep Vein Thrombosis 1Thromboembolism 1Thrombocytopenia 1Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Mesenteric Ischemia 1Lymphoma 1Leukemia 1Intracranial Thrombosis 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Endometrial Neoplasms 1Embolism 1Catheter-Related Infections 1Astrocytoma 1

Interventions

isoquercitrin 1apixaban 1Tinzaparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thromboembolism × apixaban × Classical hematology × Clear all
NCT06886516 2026-04-15

Apixaban in Thrombocytopenia

Beth Israel Deaconess Medical Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡